Stempoint Capital’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.75M Buy
+123,760
New +$4.67M 0.85% 36
2026
Q1
– Sell
-161,659
Closed -$5.59M – 97
2025
Q4
$5.59M Sell
161,659
-210,166
-57% -$6.7M 0.96% 35
2025
Q3
$10.1M Buy
371,825
+205,940
+124% +$4.98M 2.03% 12
2025
Q2
$3.49M Buy
165,885
+98,886
+148% +$1.9M 1.12% 27
2025
Q1
$1.1M Buy
+66,999
New +$1.43M 0.35% 42
2024
Q4
– Sell
-132,703
Closed -$4.2M – 66
2024
Q3
$4.2M Buy
132,703
+30,916
+30% +$1.17M 1.26% 26
2024
Q2
$3.57M Buy
101,787
+14,394
+16% +$570K 1.05% 30
2024
Q1
$3.83M Buy
+87,393
New +$3.76M 1.01% 29

Other funds holding IDYA

Stempoint Capital's IDYA Position: Q3 2026 in Review

Stempoint Capital opened a new position in IDEAYA Biosciences (IDYA) in Q3 2026: 123,760 shares worth $4.75M. The stake represents 0.85% of the portfolio and ranks #36 among its holdings. This is a return to the name: Stempoint Capital previously reported a position in IDYA as recently as Q4 2025.

Stempoint Capital first reported a position in IDYA in Q1 2024 and has held it in 8 quarters since. The position peaked at $10.1M in Q3 2025. 280 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Stempoint Capital held 123,760 shares of IDEAYA Biosciences worth $4.75M as of Q3 2026.
  • IDEAYA Biosciences was a new Stempoint Capital position in Q3 2026.
  • IDEAYA Biosciences made up 0.85% of Stempoint Capital's portfolio in Q3 2026, its #36 holding.
  • Stempoint Capital first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 8 quarters since.
  • Stempoint Capital's IDEAYA Biosciences position peaked at $10.1M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.